Adverse Reaction Reporting for Naxitamab in Chinese Expanded Access Treatment for Relapsed/Refractory High-Risk Neuroblastoma at the Children's Hospital of Fudan University
复旦大学附属儿童医院中国复发/难治性高危神经母细胞瘤扩大用药治疗中纳西他单抗不良反应报告
期刊:Drugs-Real World Outcomes
影响因子:1.9
doi:10.1007/s40801-024-00468-5
Qian, Xiaowen; Zhang, Dufei; Li, Kai; Chen, Weiming; Zhuang, Peijun; Wang, Hongsheng; Lei, Zhixian; Li, Yan; Eldridge, James; Dong, Kuiran; Zhai, Xiaowen